Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells

Journal of Pathology

Volumn 201, Issue 3, 2003, Pages 413-420

  Emmerich, Florian ^a   Theurich, Sebastian ^a   Hummel, Michael ^b   Haeffker, Antje ^a   Vry, Magnus S ^a   Döhner, Konstanze ^c   Bommert, Kurt ^d   Stein, Harald ^b   Dörken, Bernd ^a,d  

^a Section of Pathology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Hodgkin Reed Sternberg cells; I kappa B epsilon mutations; NF kappa B

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; I KAPPA B EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; HEMIZYGOSITY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REED STERNBERG CELL; SOMATIC MUTATION; STOP CODON;

BLOTTING, WESTERN; CHROMOSOME MAPPING; CLONING, MOLECULAR; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; I-KAPPA B PROTEINS; MUTATION; NEOPLASM PROTEINS; NF-KAPPA B; POLYMERASE CHAIN REACTION; REED-STERNBERG CELLS; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0242391871     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1454     Document Type: Article

References (29)

1. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
2. Wulczyn FG, Krappmann D, Scheidereit C. The NF-κB and IκB gene families: mediators of immune response and inflammation. J Mol Med 1996; 74: 749-769.
3. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
4. Verma IM, Stevenson EM, Schwarz DM, Van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 1995; 9: 2723-2735.
5. Karin M. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 1999; 274: 27 339-27 342.
6. Kaufman D, Longo DL. Hodgkin's disease. Crit Rev Oncol Hematol 1992; 13: 135-187.
7. Drexler H-G. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993; 9: 1-25.
8. Stein H, Hummel M, Dürkop H, Foss HD, Herbst H. Biology of Hodgkin's disease. In The Lymphomas, Canellos GP, Lister TA, Sklar J (eds). Saunders: Philadelphia, PA, 1998: 287.
9. Marafioti T, Hummel M, Foss H-D, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000: 95: 1443-1450.
10. Kanzler K, Küppers R, Helmes S. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000; 95: 1023-1035.
11. Stein H, Marafioti T, Foss H-D, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin's disease correlates with immunoglobulin transcription. Blood 2001; 97: 496-501.
12. Theil J, Laumen H, Marafioti T, et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 2001; 97: 3191-3196.
13. Bargou RC, Leng C, Krappmann D, et al. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340-4347.
14. Bargou RC, Emmerich F, Krappmann D, et al. Constitutive NF-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961-2969.
15. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 1999; 18: 943-953.
16. Emmerich F, Meiser M, Hummel M, et al. Overexpression of I kappa B alpha without inhibition of NF-kappa B activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999; 94: 3129-3134.
17. Cabannes E, Khan G, Aillet F, Jarret RF, Hay RT. Mutations in the IκBa gene in Hodgkin's disease suggest a tumor suppressor role for IκBα. Oncogene 1999; 18: 3063-3070.
18. Jungnickel B, Staratscheck-Jox A, Bräuninger A, et al. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191: 395-402.
19. Li Z, Nabel GJ. A new member of the IκB protein family, IκBE, inhibits RelA(p65)-mediated NF-κB transcription. Mol Cell Biol 1997; 17: 6184-6190.
20. Fischer K, Scholl C, Salat J, et al. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 1996; 88: 3962-3971.
21. Armbinder RF, Weiss LM. Association of Epstein-Barr virus with Hodgkin's disease. In Hodgkin's Disease, Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM (eds). Lippincott Williams and Wilkins: Philadelphia, 1999; 79-98.
22. Hammarskjöld ML, Simurda MC. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J Virol 1992; 66: 6496-6501.
23. Martin-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474-1477.
24. Whiteside ST, Epinat J-C, Rice N, Israel A. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J 1997; 16: 1413-1426.
25. Zhuang Y, Weiner AW. A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation. Cell 1986; 46: 827-835.
26. Bromidge T, Lowe C, Prentice A, Johnson S. p53 point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia. Br J Haematol 2000; 11: 223-229.
27. Schaffner C, Idler I, Stilgenbauer S, Döhner H, Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. PNAS 2000; 97: 2773-2778.
28. Mémet S, Laouini D, Epinat J-C, et al. IκBE deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis. J Immunol 1999; 163: 5994-6005.
29. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167-170.